Just Do It: Lilly CEO Ricks On Rebates At The Pharmacy Counter
Executive Summary
Lilly's chief exec came out strongly in favor of passing rebates onto patients at the point of sale, a big issue of debate in the industry. While it's not surprising that Lilly would be in favor of such a move, Ricks was more outspoken than some of his peers have been.
You may also be interested in...
Mylan's Semglee Launch Marks US Multi-Source Competition To Lantus
Mylan is the first to launch insulin glargine competition in both a vial and pre-filled pen, joining Eli Lilly's Basaglar pen.
FDA's Gottlieb Applauds Drug Rebates At Point-Of-Sale
The US FDA commissioner called recent initiatives to get drug rebates to patients at point-of-sale "healthy" public policy, and suggested insurance premiums have been subsidized by sick patients, addressing CNBC's health care conference.
FDA's Gottlieb Applauds Drug Rebates At Point-Of-Sale
The US FDA commissioner called recent initiatives to get drug rebates to patients at point-of-sale "healthy" public policy, and suggested insurance premiums have been subsidized by sick patients, addressing CNBC's health care conference.